Company Filing History:
Years Active: 1999
Title: David R Luthin: Innovator in Pharmaceutical Chemistry
Introduction
David R Luthin is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various health disorders. His innovative work has the potential to impact the treatment of several stress-related diseases and psychiatric conditions.
Latest Patents
David R Luthin holds a patent for "Benzoperimidine-carboxylic acids and derivatives thereof." This patent includes Benzo(e)perimidine-4-carboxamide derivatives, which are designed to interact with receptors of corticotropin-releasing factor (CRF). The compounds developed under this patent are useful in treating a range of conditions, including anxiety, depression, and other stress-related diseases. His work is particularly relevant for addressing cardiovascular, neurological, and psychiatric disorders.
Career Highlights
Luthin's career is marked by his role at Alanex Corporation, where he has been instrumental in advancing research and development in pharmaceutical applications. His innovative approach and dedication to improving health outcomes have established him as a key figure in his field.
Collaborations
Throughout his career, David R Luthin has collaborated with talented professionals, including Aleksandr K Rabinovich and Dale S Dhanoa. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
David R Luthin's contributions to pharmaceutical chemistry through his innovative patents and collaborative efforts highlight his commitment to improving health outcomes. His work continues to pave the way for advancements in the treatment of various disorders.